Recruiting

Post-filter Hct

Sponsor:

Gwyndolyn M. Radford

Code:

NCT07293936

Conditions

Continuous Renal Replacement Therapy

Renal Failure

Hemofilter Clotting

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Calculated Post-Filter Hematocrit

Measured Post-Filter Hematocrit

Study Details

Brief summary:

Filter clotting is a major complication of continuous renal replacement therapy (CRRT), resulting in blood loss, reduced treatment efficacy, and increased cost. One modifiable factor associated with filter clotting is filtration fraction (FF), or the proportion of plasma water being removed from the blood over the course of the filter. In convention, a cutoff of FF<20-30% has been used to prevent hemofilter clotting, but no evidence correlating FF with hemofilter clotting has been documented. Some experts have proposed that post-filter hematocrit (Hct) could be a more direct marker for determining hemofilter clotting risk, but evidence supporting clinical utility of this marker is lacking.

HCTpost=HCTpre/(FF(HCTpre-1)+1)

In our proposed validation study, we hope to determine whether our formula for post-filter Hct provides accurate results when compared to measured values. The information obtained from this study will potentially justify the use of utilizing the formula in future studies.

The procedure of this study is collecting blood samples from the post-filter lines of patients on CRRT at different time points and different flow rates. This will be considered the "measured post-filter hematocrit" which will then be compared to the calculated formula above, using the other values obtained from daily labs (for pre-filter hematocrit) and CRRT machine settings.

Conditions

Continuous Renal Replacement Therapy

Renal Failure

Hemofilter Clotting

Study ID

NCT07293936

Start date

Mar 15, 2025

Status verified date

Dec, 2025

Completion date

Mar 15, 2026

Anticipated

Primary completion date

Feb 1, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • patients initiated on CRRT age equal than or greater to 18 years of age

Exclusion Criteria:

  • patients on ECMO

Study Design

Enrollment

20 participants

Anticipated

Intervention Model

Single group

Primary purpose

Other

Interventions and Outcome Measures

Arms

other: CRRT patients

All participants will receive the same "intervention" of both measuring and calculating post-filter hematocrit.

Interventions

Calculated Post-Filter Hematocrit

using the formula: HCTpost=HCTpre/(FF(HCTpre-1)+1)

Measured Post-Filter Hematocrit

Measured from blood sample taken from CRRT machine

Primary outcome measure

  • Agreement between measured and calculated post-filter hematocrit values. [ Time Frame: Participation begins at consent and includes a single study procedure in which four post-filter blood samples are collected over ~40 minutes. Participation ends after the final draw. Generally, no longer than 1 day. ]

Central Contacts and Locations

Central contacts

Gwyndolyn M Radford, MD

7858179620gradford@uiowa.edu

Locations

University of Iowa Hospitals and Clinics

Recruiting

Iowa City, Iowa, United States, 52242

Contacts

More Information

Sponsor

Gwyndolyn M. Radford

Last update posted

Dec 19, 2025

Last verified

Dec, 2025

Keywords

  • crrt
  • continuous renal replacement therapy
  • hemofilter clotting
  • post-filter hematocrit
  • filtration fraction

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Gwyndolyn M. Radford on 2025-12-19.